# EpiNexus Dual License

EpiNexus is available under two licenses:

1. **Academic/Non-Commercial License** (AGPL-3.0) - Free for academic and non-commercial use
2. **Commercial License** - Required for commercial/for-profit use

---

## Academic/Non-Commercial Use (AGPL-3.0)

For academic institutions, research organizations, non-profits, and individual researchers,
EpiNexus is licensed under the GNU Affero General Public License v3.0 (AGPL-3.0).

You may use, modify, and distribute EpiNexus freely under AGPL-3.0 if:
- You are affiliated with an academic institution, research organization, or non-profit
- Your use is for non-commercial research or educational purposes
- You comply with AGPL-3.0 terms (including sharing modifications)

See LICENSE-ACADEMIC for the full AGPL-3.0 license text.

---

## Commercial Use

Commercial entities (pharma, biotech, CROs, diagnostics companies, or any for-profit use)
require a Commercial License.

**Commercial License includes:**
- Perpetual or subscription licensing options
- No copyleft requirements (keep modifications private)
- Priority support and updates
- Custom feature development (optional)
- Indemnification and warranty

**Pricing:**
- Startup (< 50 employees): $2,500/year
- SMB (50-500 employees): $10,000/year
- Enterprise (500+ employees): Contact for quote
- One-time perpetual: 3x annual rate

**Contact for Commercial Licensing:**
- Email: licensing@epinexus.org
- Web: https://epinexus.org/commercial

---

## Which License Do I Need?

| You are... | License Needed |
|------------|----------------|
| University researcher | Academic (Free) |
| Graduate student | Academic (Free) |
| Non-profit research institute | Academic (Free) |
| Government research lab | Academic (Free) |
| Pharma/biotech company | Commercial (Paid) |
| Contract research organization | Commercial (Paid) |
| Diagnostics company | Commercial (Paid) |
| Startup using for product development | Commercial (Paid) |
| Consultant billing clients | Commercial (Paid) |

---

## Contributor License Agreement

By contributing to EpiNexus, you agree that your contributions may be licensed under
both the AGPL-3.0 and Commercial licenses, allowing the project to maintain dual licensing.

---

Copyright (c) 2026 EpiNexus Contributors
